CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 32 filers reported holding CARDIOME PHARMA CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $62,000 | -86.8% | 22,500 | -85.0% | 0.02% | -83.9% |
| Q3 2016 | $470,000 | -77.1% | 150,000 | -62.5% | 0.16% | -75.9% |
| Q2 2016 | $2,048,000 | -0.9% | 400,000 | -20.9% | 0.64% | +14.6% |
| Q1 2016 | $2,067,000 | -64.0% | 505,420 | -28.7% | 0.56% | -52.9% |
| Q4 2015 | $5,749,000 | -1.7% | 708,888 | +2.3% | 1.19% | +0.5% |
| Q3 2015 | $5,850,000 | +23.5% | 693,122 | +37.7% | 1.18% | +36.6% |
| Q2 2015 | $4,735,000 | +73.1% | 503,222 | +70.4% | 0.87% | +76.0% |
| Q1 2015 | $2,735,000 | +224.1% | 295,354 | +223.6% | 0.49% | +392.0% |
| Q4 2014 | $844,000 | -34.1% | 91,274 | -36.3% | 0.10% | +29.9% |
| Q3 2014 | $1,280,000 | +13.6% | 143,303 | -0.2% | 0.08% | +54.0% |
| Q2 2014 | $1,127,000 | +76.1% | 143,523 | +77.3% | 0.05% | +194.1% |
| Q1 2014 | $640,000 | – | 80,950 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alistair Capital Management, L.L.C. | 917,400 | $5,715,000 | 2.56% |
| Fortress Investment Group LLC | 2,481,596 | $15,460,000 | 0.24% |
| PERKINS CAPITAL MANAGEMENT INC | 14,000 | $87,000 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,332,260 | $8,386,000 | 0.02% |
| TFS CAPITAL LLC | 26,116 | $163,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 54,815 | $342,000 | 0.01% |
| Renaissance Technologies | 218,913 | $1,364,000 | 0.00% |
| Alberta Investment Management Corp | 19,140 | $128,000 | 0.00% |
| OAK RIDGE INVESTMENTS LLC | 11,055 | $69,000 | 0.00% |
| SUMMIT SECURITIES GROUP LLC | 600 | $4,000 | 0.00% |